Nucala 100mg Injection
Salt Composition: Mepolizumab (100mg)
Expiry Date: 01/2028
Inclusive of all taxes
1 Vail
About The Product
Nucala 100mg Injection is a prescription medicine. It is used as an add-on treatment of severe asthma in patients 6 years and older with an eosinophilic phenotype. You should not use this medicine to treat sudden breathing problems.
Nucala 100mg Injection is a prescription medicine with active ingredient Mepolizumab (100mg). This injection is used as an add-on treatment of severe asthma in patients 6 years & older with an eosinophilic phenotype.
It should not be used to treat sudden breathing problems. It works by inhibiting the action of certain natural substances that promote symptoms of asthma. It can only be given by a doctor or nurse under strict medical supervision. Don't self administer it.
Uses
- Treatment and prevention of Asthma
- Psoriasis
- Multiple sclerosis (MS)
Side Effects
Most side effects of Nucala 100mg Injection do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common side effects include:
- Headache
- Injection site reactions (pain, swelling, redness)
- Back pain
- Fatigue
How To Use
- Nucala 100mg is available in injection form and is advised to be taken as per the doctor's prescription.
- It can only be given by a doctor or nurse under strict medical supervision.
- Taking this injection in the wrong way may give you severe side effects.
- In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention.
How It Works
Nucala 100mg Injection is a prescription based medicine with active ingredient Mepolizumab (100mg).
It belongs to the monoclonal antibodies class of drugs that work by inhibiting the action of certain natural substances that promote symptoms of asthma like cough, difficulty breathing, chest pain, and wheezing.
Safety Advice
FAQs
Nucala 100mg is belongs to the monoclonal antibodies class of drugs that work by inhibiting the action of certain natural substances that promote symptoms of asthma like cough, difficulty breathing, chest pain, and wheezing.
References
- Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., ... & Chanez, P. (2014). Mepolizumab treatment in patients with severe eosinophilic asthma. New England journal of medicine, 371(13), 1198-1207.
- Robinson, D. S. (2013). Mepolizumab treatment for asthma. Expert Opinion on Biological Therapy, 13(2), 295-302.
- Zanghì, A., Di Filippo, P. S., Rutigliano, C., Avolio, C., & D’Amico, E. (2025). Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab. Frontiers in Immunology, 16, 1634477.
- Bourdin, A., Husereau, D., Molinari, N., Golam, S., Siddiqui, M. K., Lindner, L., & Xu, X. (2020). Matching‐adjusted comparison of oral corticosteroid reduction in asthma: systematic review of biologics. Clinical & Experimental Allergy, 50(4), 442-452.
- Ennis, D., Lee, J. K., & Pagnoux, C. (2019). Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. Expert Opinion on Biological Therapy, 19(7), 617-630.
- Ennis, D., Lee, J. K., & Pagnoux, C. (2019). Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. Expert Opinion on Biological Therapy, 19(7), 617-630.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
